bioAffinity Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIAF and other ETFs, options, and stocks.

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. 

CEO
Maria Zannes
CEOMaria Zannes
Employees
57
Employees57
Headquarters
San Antonio, Texas
HeadquartersSan Antonio, Texas
Founded
2014
Founded2014
Employees
57
Employees57

BIAF Key Statistics

Market cap
9.29M
Market cap9.29M
Price-Earnings ratio
-0.68
Price-Earnings ratio-0.68
Dividend yield
—
Dividend yield—
Average volume
266.02K
Average volume266.02K
High today
$0.5298
High today$0.5298
Low today
$0.4611
Low today$0.4611
Open price
$0.4947
Open price$0.4947
Volume
146.73K
Volume146.73K
52 Week high
$2.99
52 Week high$2.99
52 Week low
$0.2404
52 Week low$0.2404
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.